Alternative Oxidase (AtAox) c78s Mutant Expression at Escherichia coli (SASX41DB)
Clicks: 234
ID: 33919
2007
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
63.3
/100
224 views
181 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Alternative oxidase (AOX) is the terminal oxidase operating in the mitochondrial electron transport chain. The enzyme is activated by organic acid such as pyruvate and by reduction process. Based on sequences alignment of alternative oxidase gene (Aox) found in several organisms, there are 2 conserved cysteine residues. In order to investigate the importance of those cysteine residues on the activity of AOX, mutation at cysteine residue number 78 of Aox gene isolated from Arabidopsis thaliana (AtAox) was conducted. Cysteine at position number 78 was changed into serine and the c78s mutant was expressed in Escherichia coli strain SASX41DB. This particular E. coli strain is unable to grow aerobically unless transformed with Arabidopsis Aox gene (AtAox). Expression studies on c78s mutant showed that this mutant cannot be oxididized and can not be activated by pyruvic acid. This mutant is acivated by succinate instead of pyruvate. Mutation at cysteine closer to the N residue is affecting both organic acid and redox activation. Therefore, it is concluded that cysteine residue closer to the N residue is the site for both activation by pyruvate as well as activation by reduction process. Keywords : Alternative oxidase, site-directed mutation, SASx41DB, cysteine residues
| Reference Key |
djajanegara2007alternativeindonesian
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ira Djajanegara; |
| Journal | indonesian journal of biotechnology |
| Year | 2007 |
| DOI |
10.22146/ijbiotech.7766
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.